4th Quarter - Report

ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) for GENUS MEDICAL TECHNOLOGIES

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to FDA; S. 4358, FDASLA; H.R. 7667, Food and Drug Amendments Act

LobbyistCovered position, as disclosed
STEVEN E IRIZARRY —
VINCENT A. ROBERTI, SR. —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 4358 (117th), H.R. 7667 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.